Get 40% Off
💰 Ray Dalio just increased his holdings in Google by 162.61% - See the full portfolio with InvestingPro’s free Stock Ideas toolCopy Portfolios

NASDAQ Biotechnology (NBI)

NASDAQ
Currency in USD
Disclaimer
4,454.2
+49.4(+1.12%)
Real-time Data
Day's Range
4,433.44,472.7
52 wk Range
3,630.44,596.8
Prev. Close
4,404.8
Open
4,447.4
1-Year Change
3.36%
Volume
0
Average Vol. (3m)
1
Day's Range
4,433.4-4,472.7
52 wk Range
3,630.4-4,596.8
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Daily
Weekly
Monthly
More
Type:Index
# Components:218

People Also Watch

774.59
DJUSEN
-0.01%
948.63
DJU
+0.87%
6,684.7
IXTR
+0.13%
3,788.1
IXBK
+0.02%
5,963.1
DJUSTC
+2.12%
How do you feel today about NBI?
Vote to see community's results!
or
NameVol.Price
IBB
iShares Nasdaq Biotechnology
819.71K137.40+1.42%
IBBQ
Invesco Nasdaq Biotechnology
9.34K22.33+1.29%
NameVol.Price
NVAX
Novavax Inc
21.22M12.801-5.04%
PACB
Pacific Biosciences of California
12.45M2.125-4.71%
ARQT
Arcutis Biotherapeutics Inc
11.09M9.22+13.41%
BCRX
BioCryst Pharmaceuticals Inc
8.23M6.39+19.22%
RXRX
Recursion Pharmaceuticals Inc
5.38M10.04-0.10%

Top Gainers

NamePrice
TSHA
Taysha Gene
3.095+0.525+20.43%
BCRX
BioCryst
6.39+1.030+19.22%
ARQT
Arcutis
9.22+1.09+13.41%
PLRX
Pliant
15.80+1.66+11.74%
CABA
Cabaletta Bio
12.59+1.360+12.11%

Top Losers

NamePrice
AVIR
Atea
3.665-0.295-7.45%
NVAX
Novavax
12.801-0.679-5.04%
SMMT
Summit Therapeutics PLC
4.47-0.215-4.59%
TERN
Terns Pharmaceuticals
5.76-0.230-3.84%
PACB
Pacific Biosciences
2.125-0.105-4.71%
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.